Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-10 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ORGS | Orgenesis | 6.89 | -0.21 | -2.96% | 166.4M |
You can purchase shares of Orgenesis (NASDAQ: ORGS) through any online brokerage.
Other companies in Orgenesis’s space includes: DiaMedica Therapeutics (NASDAQ:DMAC), GlycoMimetics (NASDAQ:GLYC) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Orgenesis (NASDAQ: ORGS) was reported by Benchmark on 2019-09-26. The analyst firm set a price target for 9.00 expecting ORGS to rise to within 12 months (a possible 30.62% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Orgenesis (NASDAQ: ORGS) is $6.89 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Orgenesis.
There is no upcoming split for Orgenesis.